These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 15462188

  • 1. In vitro and in vivo antimycobacterial activity of antiinflammatory drug, diclofenac sodium.
    Dutta NK, Kumar KA, Mazumdar K, Dastidar SG.
    Indian J Exp Biol; 2004 Sep; 42(9):922-7. PubMed ID: 15462188
    [Abstract] [Full Text] [Related]

  • 2. Antibacterial activity of the antiinflammatory agent diclofenac sodium.
    Annadurai S, Basu S, Ray S, Dastidar SG, Chakrabarty AN.
    Indian J Exp Biol; 1998 Jan; 36(1):86-90. PubMed ID: 9536657
    [Abstract] [Full Text] [Related]

  • 3. In vitro and in vivo antimycobacterial activity of an antihypertensive agent methyl-L-DOPA.
    Dutta NK, Mazumdar K, Dastidar SG, Chakrabarty AN, Shirataki Y, Motohashi N.
    In Vivo; 2005 Jan; 19(3):539-45. PubMed ID: 15875773
    [Abstract] [Full Text] [Related]

  • 4. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice.
    Dutta NK, Mazumdar K, Dastidar SG, Park JH.
    Int J Antimicrob Agents; 2007 Oct; 30(4):336-40. PubMed ID: 17644321
    [Abstract] [Full Text] [Related]

  • 5. Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium.
    Dutta NK, Annadurai S, Mazumdar K, Dastidar SG, Kristiansen JE, Molnar J, Martins M, Amaral L.
    Int J Antimicrob Agents; 2007 Sep; 30(3):242-9. PubMed ID: 17644318
    [Abstract] [Full Text] [Related]

  • 6. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Sohn H, Lee KS, Ko YK, Ryu JW, Woo JC, Koo DW, Shin SJ, Ahn SJ, Shin AR, Song CH, Jo EK, Park JK, Kim HJ.
    Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
    [Abstract] [Full Text] [Related]

  • 7. Experimental studies on synergism between aminoglycosides and the antimicrobial antiinflammatory agent diclofenac sodium.
    Annadurai S, Guha-Thakurta A, Sa B, Dastidar SG, Ray R, Chakrabarty AN.
    J Chemother; 2002 Feb; 14(1):47-53. PubMed ID: 11892899
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The effects of diclofenac sodium on thyroid function tests in vivo and in vitro].
    Aoyama A, Natori Y, Yamaguti N, Koike S, Kusakabe K, Demura R, Demura H.
    Rinsho Byori; 1990 Jun; 38(6):688-92. PubMed ID: 2381092
    [Abstract] [Full Text] [Related]

  • 10. The relationship between the in vitro drug susceptibility of opportunist mycobacteria and their in vivo response to treatment.
    Heginbothom ML.
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):539-45. PubMed ID: 11409581
    [Abstract] [Full Text] [Related]

  • 11. Antimicrobial potentiality of the thioxanthene flupenthixol through extensive in vitro and in vivo experiments.
    Jeyaseeli L, Gupta AD, Asok Kumar K, Mazumdar K, Dutta NK, Dastidar SG.
    Int J Antimicrob Agents; 2006 Jan; 27(1):58-62. PubMed ID: 16316745
    [Abstract] [Full Text] [Related]

  • 12. Diclofenac in the management of E. coli urinary tract infections.
    Mazumdar K, Dutta NK, Dastidar SG, Motohashi N, Shirataki Y.
    In Vivo; 2006 Jan; 20(5):613-9. PubMed ID: 17091768
    [Abstract] [Full Text] [Related]

  • 13. [Mycobacterial bases of the therapy of mycobacterioses].
    Hejný J.
    Z Erkr Atmungsorgane; 1982 Jan; 158(1-2):163-7. PubMed ID: 7072265
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates.
    Erturan Z, Uzun M.
    Int J Antimicrob Agents; 2005 Jul; 26(1):78-80. PubMed ID: 15950439
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The potential of South African plants against Mycobacterium infections.
    McGaw LJ, Lall N, Meyer JJ, Eloff JN.
    J Ethnopharmacol; 2008 Oct 28; 119(3):482-500. PubMed ID: 18805475
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
    Zanetti S, Sechi LA, Molicotti P, Cannas S, Bua A, Deriu A, Carta A, Paglietti G.
    Int J Antimicrob Agents; 2005 Feb 28; 25(2):179-81. PubMed ID: 15664491
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.